XML 22 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities:      
Net (loss) income $ (372,503) $ (274,285) $ 387,011
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation 381,760 493,162 456,483
Loss on impairment of assets 678,145 860,441 109,462
Loss (gain) on disposition of assets 3,795 (2,290) (5,382)
Loss on sale of marketable securities, net 12,146    
Loss (gain) on foreign currency forward exchange contracts   8,364 (3,275)
Deferred tax provision (106,263) (242,034) 1,532
Stock-based compensation expense 4,880 4,856 3,507
Deferred income, net (29,108) (45,383) 60,061
Deferred expenses, net (20,155) (26,405) (82,814)
Other assets, noncurrent (4,914) 2,483 2,881
Other liabilities, noncurrent (31) (3,890) (3,979)
(Payments of) proceeds from settlement of foreign currency forward exchange contracts designated as accounting hedges   (8,364) 3,275
Bank deposits denominated in nonconvertible currencies 3,475 1,069 5,520
Other 2,216 (211) 3,118
Changes in operating assets and liabilities:      
Accounts receivable 159,098 58,872 5,269
Prepaid expenses and other current assets 6,187 19,195 (2,791)
Accounts payable and accrued liabilities (71,085) (180,872) 27,463
Taxes payable (1,089) 71,719 25,490
Net cash provided by operating activities 646,554 736,427 992,831
Investing activities:      
Capital expenditures (including rig construction) (652,673) (830,655) (2,032,764)
Proceeds from disposition of assets, net of disposal costs 221,722 13,049 18,318
Proceeds from sale and maturities of marketable securities 4,614 51 8,000,057
Purchases of marketable securities     (6,265,846)
Net cash used in investing activities (426,337) (817,555) (280,235)
Financing activities:      
Repayment of long-term debt   (250,000) (250,000)
(Repayment of) proceeds from short-term borrowings, net (182,389) 286,589  
Debt issuance costs and arrangement fees (215) (624) (2,249)
Payment of dividends and anti-dilution payments (408) (69,432) (486,240)
Purchase of treasury stock     (87,756)
Other     261
Net cash used in financing activities (183,012) (33,467) (825,984)
Net change in cash and cash equivalents 37,205 (114,595) (113,388)
Cash and cash equivalents, beginning of year 119,028 233,623 347,011
Cash and cash equivalents, end of year $ 156,233 $ 119,028 $ 233,623